BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 6223093)

  • 1. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
    Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
    J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
    Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
    J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2.
    Takada S; Ueda Y; Suzuki N; Murakawa Y; Hoshino T; Green I; Steinberg AD; Horwitz DA; Sakane T
    Eur J Immunol; 1985 Mar; 15(3):262-7. PubMed ID: 3156746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.
    Kotani H; Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    Clin Exp Immunol; 1984 May; 56(2):390-8. PubMed ID: 6234113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
    Perl A; Gonzalez-Cabello R; Gergely P
    J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
    Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
    J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin.
    Niwa Y; Sakane T; Fukuda Y; Miyachi Y; Kanoh T
    J Clin Lab Immunol; 1985 May; 17(1):37-44. PubMed ID: 2931529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological functions of T-cell surface glycoproteins.
    Thomas Y; Lederman S; Rogozinski L; Chess L
    Diagn Immunol; 1983; 1(3):100-3. PubMed ID: 6238748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the defective T cell regulation of the antigen-specific PFC response in SLE patients: differentiation of suppressor precursor cells to suppressor effector cells.
    Heijnen CJ; Pot KH; Kater L; Kluin-Nelemans HC; Uytdehaag F; Ballieux RE
    Clin Exp Immunol; 1982 Feb; 47(2):359-67. PubMed ID: 6210474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the autologous MLR in primary biliary cirrhosis: evidence that the autologous MLR is a negative feedblock response stimulated by activated B cells.
    James SP; Yenokida GG; Strober W
    Behring Inst Mitt; 1983 May; (72):177-87. PubMed ID: 6242336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
    Huang YP; Miescher PA; Zubler RH
    J Immunol; 1986 Dec; 137(11):3515-20. PubMed ID: 2946762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
    J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
    Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
    J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils.
    Niwa Y; Sakane T; Shingu M; Yokoyama M
    J Clin Lab Immunol; 1984 May; 14(1):35-43. PubMed ID: 6086929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.